The epigenetic impact of suberohydroxamic acid and 5‑Aza‑2'‑deoxycytidine on DNMT3B expression in myeloma cell lines differing in IL‑6 expression

MLA

Katerina Smesny, Trtkova, et al. “The Epigenetic Impact of Suberohydroxamic Acid and 5‑Aza‑2’‑deoxycytidine on DNMT3B Expression in Myeloma Cell Lines Differing in IL‑6 Expression.” Molecular Medicine Reports, vol. 26, Aug. 2022. EBSCOhost, https://doi.org/10.3892/mmr.2022.12837.

APA

Katerina Smesny, T., Petra, L., Denisa Weiser, D., Katerina, C., Lucie, J., Jan, G., Dana, P., Ivo, F., Marian, H., & Jiri, M. (2022). The epigenetic impact of suberohydroxamic acid and 5‑Aza‑2’‑deoxycytidine on DNMT3B expression in myeloma cell lines differing in IL‑6 expression. Molecular Medicine Reports, 26. https://doi.org/10.3892/mmr.2022.12837

Chicago

Katerina Smesny, Trtkova, Luzna Petra, Drozdkova Denisa Weiser, Cizkova Katerina, Janovska Lucie, Gursky Jan, Prukova Dana, Frydrych Ivo, Hajduch Marian, and Minarik Jiri. 2022. “The Epigenetic Impact of Suberohydroxamic Acid and 5‑Aza‑2’‑deoxycytidine on DNMT3B Expression in Myeloma Cell Lines Differing in IL‑6 Expression.” Molecular Medicine Reports 26 (August). doi:10.3892/mmr.2022.12837.